-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Downgrades Insulet to Market Perform, Lowers Price Target to $145

Benzinga·08/06/2026 20:44:46
Listen to the news
Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market Perform and lowers the price target from $247 to $145.